Form 8-K - Current report:
SEC Accession No. 0001193125-25-155830
Filing Date
2025-07-07
Accepted
2025-07-07 07:30:42
Documents
21
Period of Report
2025-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d15686d8k.htm   iXBRL 8-K 39040
2 EX-1.1 d15686dex11.htm EX-1.1 207791
3 EX-4.1 d15686dex41.htm EX-4.1 79648
4 EX-4.2 d15686dex42.htm EX-4.2 85076
5 EX-4.3 d15686dex43.htm EX-4.3 85597
6 EX-5.1 d15686dex51.htm EX-5.1 15166
7 EX-99.1 d15686dex991.htm EX-99.1 7724
8 EX-99.2 d15686dex992.htm EX-99.2 8917
12 GRAPHIC g15686g0704034958204.jpg GRAPHIC 2406
13 GRAPHIC g15686g0704034958450.jpg GRAPHIC 4582
  Complete submission text file 0001193125-25-155830.txt   799770

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA ino-20250702.xsd EX-101.SCH 2831
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20250702_lab.xml EX-101.LAB 17993
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20250702_pre.xml EX-101.PRE 11249
23 EXTRACTED XBRL INSTANCE DOCUMENT d15686d8k_htm.xml XML 3642
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 251106985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)